MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3978/j.issn.2225-319x.2015.08.13

Медицинская библиотека · Annals of cardiothoracic surgery · 2016

Multi-institutional European experience of robotic thymectomy for thymoma.

Marulli Giuseppe, Maessen Jos, Melfi Franca, Schmid Thomas A, Keijzers Marlies, Fanucchi Olivia, Augustin Florian, Comacchio Giovanni M, Mussi Alfredo, Hochstenbag Monique, Rea Federico

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Robotic thymectomy for early-stage thymomas has been recently suggested as a technically sound and safe approach. However, due to a lack of data on long term results, controversy still exists regarding its oncological efficacy. In this multi-institutional series collected from four European Centres with high volumes of robotic procedures, we evaluate the results after robot-assisted thoracoscopic thymectomy for thymoma.

METHODS

Between 2002 and 2014, 134 patients (61 males and 73 females, median age 59 years) with a clinical diagnosis of thymoma were operated on using a left-sided (38%), right-sided (59.8%) or bilateral (2.2%) robotic approach. Seventy (52%) patients had associated myasthenia gravis (MG).

RESULTS

The average operative time was 146 minutes (range, 60-353 minutes). Twelve (8.9%) patients needed open conversion: in one case, a standard thoracoscopy was performed after robotic system breakdown, and in six cases, an additional access was required. Neither vascular and nerve injuries, nor perioperative mortality occurred. A total of 23 (17.1%) patients experienced postoperative complications. Median hospital stay was 4 days (range, 2-35 days). Mean diameter of resected tumors was 4.4 cm (range, 1-10 cm), Masaoka stage was I in 46 (34.4%) patients, II in 71 (52.9%), III in 11 (8.3%) and IVa/b in 6 (4.4%) cases. At last follow up, 131 patients were alive, three died (all from non-thymoma related causes) with a 5-year survival rate of 97%. One (0.7%) patient experienced a pleural recurrence.

CONCLUSIONS

Our data suggest that robotic thymectomy for thymoma is a technically feasible and safe procedure with low complication rates and short hospital stays. Oncological outcome appears to be good, particularly for early-stage tumors, but a longer follow-up period and more cases are necessary in order to consider this as a standard approach. Indications for robotic thymectomy for stage III or IVa thymomas are rare and should be carefully evaluated.

Для цитирования: Marulli Giuseppe, Maessen Jos, Melfi Franca, Schmid Thomas A, Keijzers Marlies, Fanucchi Olivia, Augustin Florian, Comacchio Giovanni M, Mussi Alfredo, Hochstenbag Monique, Rea Federico. Multi-institutional European experience of robotic thymectomy for thymoma.. Annals of cardiothoracic surgery. 2016. DOI: 10.3978/j.issn.2225-319x.2015.08.13.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.